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Abstract
Polypharmacy is common among multimorbid adults and associated with increased
morbidity and mortality. Excessive polypharmacy (ie, ≥10 medicine) is strongly asso-
ciated with inappropriate medication use, but little is known about attitudes toward
deprescribing in patients with excessive polypharmacy. We surveyed 100 Danish
individuals aged 65 years and above with ≥10 prescribed medications, using the val-
idated Patients’ Attitudes Towards Deprescribing (PATD) instrument. Most partici-
pants (81, 81%) thought they took a large number of medications, and 79 (79%)
believed that their medications were necessary. Even so, 85 (85%) reported that
they would be willing to stop taking one or more of their regular medications if their
doctor told them they could, and 11 (11%) felt that they took at least one regular
medication that they no longer needed. When presented with visual presentation of
various amounts of tablets and capsules, 62 (62%) of participants reported that they
would be comfortable taking fewer medications than they did. Forty‐two (42%) par-
ticipants had experience with stopping a regular medication. Almost all participants
(92%) wanted to receive follow‐up by various means if a medication was discontin-
ued. Forty‐one (41%) participants were interested in a consultation at an outpatient
clinic specializing in polypharmacy. Overall, the answers to the PATD questionnaire
suggest that our cohort of Danish, multimorbid outpatients with extensive polyphar-
macy have a high confidence in their healthcare providers for medication‐related
decisions, even though some feel that they are taking more medications than they
would like to and feel that some medications may be unnecessary. Our results
underline the need for healthcare providers to offer medication reviews in patients
with multimorbidity.
K E YWORD S
deprescribing, multimorbidity, patient perspective, polypharmacy
Abbreviations: PATD, Patients’ Attitudes Towards Deprescribing; SMC, Shared Medicine
Card; DHS, Danish Healthcare System.
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1 | INTRODUCTION
Elderly persons and those with multiple chronic medical conditions
such as chronic obstructive lung disease and diabetes are often trea-
ted with numerous drugs prescribed by several physicians.1 Concur-
rent treatment with several drugs, known as polypharmacy, is costly
for society and comprises a risk for medication interactions, adverse
effects, hospitalizations, and increased mortality.2 Excessive or severe
polypharmacy (ie ≥10 medicine) is strongly associated with inappro-
priate medication use3,4 and might represents a large pill burden to
patients. Results from prior studies indicate that it can be beneficial
to decrease the number of medications among multimorbid patients
to reduce the risk of medication‐related harms.5,6 However, few stud-
ies have investigated patients’ attitudes toward their use of medica-
tions and potential withdrawal of prescriptions, ie, deprescribing.
The Patients’ Attitudes Towards Deprescribing (PATD) instru-
ment was developed in 2013.7 Studies based on this questionnaire
from Italy8 and Australia9-11 suggest that most hospitalized older
patients,8,10 outpatients,9 and nursing home residents11 think they
take a large number of medications and would like to reduce the
number of drugs they take on a daily basis. However, patients
in these studies generally were not treated with excessive
polypharmacy.7-11
Thus, in this study we aimed to elucidate the attitudes toward
medications and potential deprescribing in a group of elderly outpa-
tients treated with excessive polypharmacy.
2 | MATERIALS AND METHODS
To examine patients’ attitudes toward medications and deprescrib-
ing, a structured questionnaire survey was conducted among individ-
uals aged 65 years and above with 10 or more prescribed
medications. Participants were recruited from two outpatient clinics
(Department of Endocrinology and Department of Respiratory Medi-
cine) at Bispebjerg and Frederiksberg University Hospital in Copen-
hagen. Patients who fulfilled the inclusion criteria: age 65 years and
above, and having 10 or more prescribed medication on the day of
their visit to one of the two outpatient clinics were included in the
study. Patients not able to cooperate in filling out the questionnaire
ie, with significant hearing impairment, limited cognitive capacity
and/or not able to speak or understand Danish were excluded.
All medications with an ATC code (including as‐needed medica-
tions) were included in the study when tallying the number of drugs.
If the same formulation and active pharmaceutical substance was
listed for both regular and as‐needed use, it counted as a single
medication. The following medications were excluded: viscous eye
drops, topical lotions, oyster shells (calcium supplementation used in
Denmark), and antibiotics. Information about the number of pre-
scribed drugs was obtained from participants prescription register
Shared Medicine Card (SMC). The SMC is a central Danish database
that contains information on all registered Danish citizens’
prescriptions for the two most recent years. During data collection,
366 patients met inclusion criteria and were scheduled with an
appointment in either the Department of Endocrinology or the
Department of Respiratory Medicine. However, a significant number
of these patients did not keep their appointments and were there-
fore not included in the study. In addition, some patients declined
participation due to fatigue, illness, or lack of time. Patients received
oral and written information about the study and gave written
informed consent to participate, including consent to access the hos-
pital electronic patient record.
We used the validated PATD instrument,12 which includes ques-
tions related to patients’ attitudes toward their health, use of medi-
cations, and challenges experienced during contact with the
healthcare system. Following World Health Organization guideli-
nes,13 we translated the questionnaire to the Danish language using
forward‐backward translation. The questionnaire was pilot tested on
five patients during interviews, and the questionnaire was revised
based on the interview results. Item 9, assessing how medication
costs impacted patients’ attitudes and willingness to deprescribe,
was modified to make it applicable to patients in the Danish Health-
care System (DHS). In the DHS, drugs prescribed at hospitals are
free at the point of delivery, but those prescribed in the primary care
sector, primarily by general practitioners, are subject to reimburse-
ment. The degree of reimbursement depends on individual patients’
annual medication costs.14 The original wording of item 9, “Having
to pay for my medications would play a role in my willingness to
stop one or more of them” was revised to “The cost of medications
impacts my willingness to stop one or more of them” in the Danish
version of PATD.
We expanded the questionnaire by including items about demo-
graphics (age, gender, and educational level), self‐rated health (one
item), and health literacy (four items from The Australian Health Lit-
eracy Questionnaire translated and validated into Danish).15 Partici-
pants were also asked whether they were interested in being
contacted for an appointment at an outpatient clinic with a special
focus on their medications.
Participants completed the questionnaire, which was distributed
and collected by a pharmacist, at the outpatient clinics and could ask
the pharmacist questions about the items in the questionnaire. The
data collection was stopped when a total of 100 patients had com-
pleted the questionnaire.
Information about the number of participants’ diagnoses was col-
lected from their electronic patient records from the hospital. Multi-
morbidity was defined as having two or more of the following
chronic conditions: diabetes, cancer, chronic back pain, osteoarthritis,
osteoporosis, joint disease, allergies, chronic obstructive pulmonary
disease, dementia (excluded from this study), schizophrenia, long‐
term use of antidepressants, anxiety, high cholesterol, hypertension,
stroke, heart disease, and chronic pain.16
The study was approved by the Danish Data Protection Agency
(No. BFH‐2016‐050). According to Danish law, ethical permission is
not required for survey studies.
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3 | RESULTS
3.1 | Participant characteristics
A total of 63 women and 37 men participated in the survey. Their
median age was 75 years (range, 65‐92), and 63 (63%) participants
had short or no further education. More than half of the participants
lived alone (69, 69%). The median number of prescribed medications
was 12 (range, 10‐32), and all participants had two or more chronic
conditions; the median number of conditions was 6 (range, 2‐11).
The most prevalent chronic condition was heart disease (87, 87%),
hypertension (86, 86%), dyslipidaemia (69, 69%), chronic pain (58,
58%), diabetes (56, 56%), COPD (42, 42%), and osteoporosis (39,
39%). More than half of the participants (59, 59%) rated their health
as fair or poor. The major part of the participants (93, 93%) reported
that they felt that it was very easy or easy to talk about health
issues with healthcare professionals and to follow guidance from
healthcare professionals (Table 1).
3.2 | Attitudes toward medications and
deprescribing
Most participants (81, 81%) thought they took a large number of
medications. Most participants (65, 65%) also reported feeling confi-
dent about taking the number of medications they did, and 79 (79%)
believed that their medications were necessary (Table 2). When
responding to visual cues showing certain amounts of tablets or cap-
sules, 62 (62%) participants reported that they would feel comfort-
able with a maximum of daily intake of eight tablets or capsules
(Table 3). Conversely, 85 (85%) reported that they would be willing
to stop taking one or more of their regular medications if their doc-
tor told them they could do so (Table 2). Approximately one in ten
(11, 11%) felt that they took at least one regular medication that
they no longer needed (Table 2).
More than two‐thirds of participants (71, 71%) reported that it
would be acceptable to take even more medications for their condi-
tions. Less than half of participants (40, 40%) believed that one or
more of their medications were causing side effects (Table 2). The
majority of participants (85, 85%) reported that they had a good
understanding of the indication for their medications. For 18 (18%)
participants, the cost of medications influenced their willingness to
stop taking them (Table 2). Less than half of participants (42, 42%)
had experience with stopping one of their regular medications: of
these, 16 (38%) reported that they did not need the withdrawed
medication, whereas 25 (60%) reported that they had to restart the
medication or start a new one (Table 3).
Asked about what type of follow‐up they would prefer if one or
more medications were withdrawn, 67 (67%) participants answered
that they would want personal contact, and 48 (48%) also wanted to
receive written information via post or e‐mail. Approximately one in
five participants (19, 19%) responded that they preferred to receive
follow‐up via telephone, and 8 (8%) participants indicated that they
wanted no follow‐up (Table 3).
Finally, 41 (41%) participants reported that they would be
interested in a consultation in an outpatient clinic focusing on
polypharmacy. A similar proportion (42, 42%) reported that they
were not interested, 15 (15%) responded that they were unsure
about whether they would like a consultation, and 2 (2%) did not
respond.
The supplementary tables revealed that there was no association
between the participants’ attitudes towards medication and depre-
scribing and self‐rated health. Likewise, we found no association
between the participants’ attitudes toward medication and depre-
scribing and health literacy.
TABLE 1 Characteristics of participants, n (%)
N = 100
Age in years, median (range) 75 (65‐92)
Gender
Male 37 (37)
Female 63 (63)
Living alone 69 (69)
Education
Short or no further education 63 (63)
Higher or postgraduate education 37 (37)
Number of prescribed medications, median (range) 12 (10‐32)
Number of chronic conditions, median (range) 6 (2‐11)
Multimorbidity (two or more chronic conditions) 100 (100)
Heart disease 87 (87)
Hypertension 86 (86)
Dyslipidemia 69 (69)
Chronic pain 58 (58)
Diabetes 56 (56)
COPD 42 (42)
Osteoporosis 39 (39)
Self‐rated health
Excellent 4 (4)
Very good 8 (8)
Good 29 (29)
Fair 38 (38)
Poor 21 (21)
Health literacy
Very easy or easy to
talk to about health issues
with healthcare professionals
93 (93)
Very easy or easy to
follow guidance from
healthcare professionals
93 (93)
Very easy or easy to read
and understand written
information about health
61 (61)
Very easy or easy to read
and understand all information
on medication packages
49 (49)
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4 | DISCUSSION
Our cohort of multimorbid, Danish outpatients taking 10 or more
medications felt that they had a large number of current prescrip-
tions, although most participants were comfortable with the number
of medications they took. Most of the participants believed that
their medications were necessary, and only few of the participants
felt that they took unnecessary medication, which contrasts with the
literature stating a high degree of inappropriate prescriptions in pop-
ulations with excessive polypharmacy.17 A previous study from the
DHS focusing on the quality of care for patients with multiple
chronic conditions, found that patients with a high number of pre-
scribed medications often have inappropriate medications on their
list of prescribed medications.1 Thus, it seems that patients with a
high number of prescribed medications can be comfortable with the
medicine they take even though some of the medicine may be inap-
propriate. In line with this, results from an Australian study focusing
on patients’ attitudes toward deprescribing showed that the willing-
ness to deprescribe depended on patients’ perceptions about medi-
cation appropriateness, fear of adverse outcomes related to
withdrawal, dislike of taking medications, and the availability of a
process for withdrawal.12
Further, when participants were presented with visual cues of
tablets and capsules, their responses suggested that they were not
comfortable with the number of medications they actually took on a
daily basis (verified by their medical records). It is unclear to what
extent participants had a full overview of their overall medication
use. Paradoxically, most participants reported a good understanding
of the reasons they were prescribed each of their medications. Thus,
differences may exist between what patients and healthcare profes-
sionals perceive as a good understanding of the rationales for
numerous medications. Although it is beyond the scope of our study,
investigating the knowledge of patients who report a good
understanding of their treatment could be an interesting focus of
future research.
Forty percent of participants believed that one or more of their
medications were causing adverse effects. Many treatments entail
adverse effects, and we expected that more participants would
ascribe symptoms to medications. The level of reported adverse
effects could indicate that some patients do not associate symptoms
they are experiencing with their medications. However, the part of
patients reporting adverse effects is consistent with results from
other studies using the PATD questionnaire.8,9
Most participants reported that they would like to withdraw one
or more of their drugs if their doctor told them that they could do so.
Half of the participants preferred that deprescribing one or more of
their drugs would be followed by a consultation with a healthcare pro-
fessional, and the other half of the participants would have liked post
or e‐mail follow‐up. Less than half of the participants answered that
they would be interested in a consultation in a specialised outpatient
clinic focusing on polypharmacy. Thus, it seems important that patients
trust the healthcare provider who conducts the deprescribing consul-
tation. Other studies have identified trust as a core facet of effective
therapeutic relationships, particularly for people with chronic illness
because of their greater vulnerability, uncertainty regarding outcomes,
and increased dependence on healthcare providers over extended
periods of time.18,19 Thus, trusting healthcare providers and the
healthcare system may be a vital strategy for individuals with chronic
illness with many prescribed medications. In addition, sufficient consul-
tation time is essential; limited consultation time results in lower trust
in patient‐physician relationships.20 Our results suggest that some
patients may prefer to have medication‐related issues followed by
their general practitioners, whereas others may prefer to be followed
by outpatient specialists with whom they have good relationships.
Our results from a Danish outpatient population are consistent
with previous studies using the PATD questionnaire among older
TABLE 2 Responses to PATD items 1‐10 (n = 100), n (%)
N = 100
Strongly
agree Agree Unsure Disagree
Strongly
disagree
1. I feel that I am taking a large number of medications 73 (73) 8 (8) 2 (2) 14 (14) 3 (3)
2. I am comfortable with the number of medications I am taking 54 (54) 11 (11) 10 (10) 22 (22) 3 (3)
3. I believe that all my medications are necessary 68 (68) 11 (11) 4 (4) 7 (7) 9 (9)
4. If my doctor said it was possible, I would be willing to stop one or more of
my regular medications
78 (78) 7 (7) 1 (1) 12 (12) 2 (2)
5. I would like to reduce the number of medications I am taking 74 (74) 8 (8) 2 (2) 11 (11) 3 (3)
6. I feel that I may be taking one or more medications that I no longer need 9 (9) 2 (2) 6 (6) 57 (57) 25 (25)
7. I would accept taking more medications for my health conditions 61 (61) 10 (10) 2 (2) 25 (25) 2 (2)
8. I have a good understanding of the reasons I was prescribed each of my
medications
83 (83) 2 (2) 3 (3) 12 (12) 0 (0)
9. The cost of medications impacts my willingness to stop one or more of
them
18 (18) 0 (0) 1 (1) 76 (76) 3 (3)
10. I believe one or more of my medications is causing side effects 35 (35) 5 (5) 2 (2) 43 (43) 14 (14)
PATD, Patients’ Attitudes Towards Deprescribing.
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inpatients in Italy and Australia.9-11 Galazzi et al.8 also reported that
the majority of study participants felt comfortable with the number
of medications they were taking. However, in these studies patients
were taking a median of six medications, compared to the median of
12 in our cohort. When using visual cues, the majority of partici-
pants in the Italian cohort reported that they would be comfortable
taking a maximum of four tablets or capsules per day. This is similar
to our findings that visual cues led to a majority of participants
reporting that they would be comfortable taking fewer medications
than they were.
Limitations of the study entail that the number of study partici-
pants were limited and recruited from selected outpatient clinics (ie,
endocrine and respiratory outpatient clinics in one hospital) and sev-
eral eligible individuals were unable to participate for reasons that
included illness and fatigue. Consequently, the study population may
include healthier individuals than are representative of the entire
Danish older outpatient population with excessive polypharmacy.
Thus, using sampling strategies to ensure that the population
included individuals from different part of the country and whose
health status and disease pattern was representative of the larger
population may have impacted the results. Another limitation of the
study is the lack of knowledge about the appropriateness of the
medication in question as well as the focus of the number of tablets
in the PATD instrument. Medication is typically not deprescribed just
to avoid tablets, but instead to improve medication appropriateness
and reduce adverse effects and interactions. Clearly, it is possible
that a medical professional relation with the patient including having
knowledge of present and previous conditions as well as the degree
of inappropriate prescribing in the individual patient may impact the
patients attitudes toward deprescribing. Nevertheless, we believe
that items used in the PATD instrument provides general indication
of older multimorbid patients’ attitudes toward medication and
TABLE 3 Responses to PATD items 11‐14, n (%)
Response options N = 100
11. Have you ever tried to stop a regular medication with the
approval of your doctor?
No 56 (56)
Yes, and I never took it again 16 (16)
Yes, but I had to start taking it again 8 (8)
Yes, but I had to take a different medicine 17 (17)
12. How many different tablets or capsules would you be
comfortable taking per day?
5‐10 39 (39)
10‐14 34 (34)
15‐19 11 (11)
20‐25 5 (5)
>25 1 (1)
13. What is the maximum number of tablets or capsules you would
be comfortable taking per day? (4)
37 (37)
(8) 25 (25)
(12) 7 (7)
(16) 2 (2)
(20) 2 (2)
(24) 6 (6)
14. If one of your regular medications were stopped, what follow‐
up would you like?
Face‐to‐face appointment 67 (67)
Telephone call 19 (19)
Written information sent by post 25 (25)
Written information sent by email 23 (23)
Contact with a health practitioner
when necessary without prescheduled follow‐up
8 (8)
PATD, Patients’ Attitudes Towards Deprescribing.
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deprescribing., A notion that is supported by the similarity of our
result with those of similar studies using PATD in other countries.
In conclusion, our survey suggests that multimorbid outpatients
with excessive polypharmacy in Denmark trust their prescribers and
feel that their pharmacotherapy is necessary and has very few or no
side effects. Paradoxically, many participants would have liked to
reduce the number of their medications, and almost half would have
liked to be invited to a specialized outpatient clinic focusing on
polypharmacy. Our findings emphasis the need for healthcare provi-
ders to offer medication reviews and provide systematic follow‐up
afterward; most patients trust their healthcare providers and cannot
be expected to request a medication review.
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